WHO ICTRP trial
Phase II study of high-dose thoracic 3D-conformal radiotherapy without elective…
JPRN-UMIN000001743 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001743 |
|---|---|
| Public title | Phase II study of high-dose thoracic 3D-conformal radiotherapy without elective nodal irradiation concurrently combined with cisplatin and vinorelbine chemotherapy in patients with inoperable stage III non-small cell lung cancer |
| Scientific title | Phase II study of high-dose thoracic 3D-conformal radiotherapy without elective nodal irradiation concurrently combined with cisplatin and vinorelbine chemotherapy in patients with inoperable stage III non-small cell lung cancer - Phase II study of high-dose thoracic and cisplatin and vinorelbine… |
| Primary sponsor | National Cancer Center Hospital |
| Secondary sponsors | Hyogo Cancer Center KKR Sapporo Medical Center National Hospital Organization Hokkaido Cancer Center Tochigi Cancer Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | inoperable stage III non-small cell lung cancer |
| Interventions | Cisplatin 80mg/m2 on day 1 + vinorelbine 20mg/m2 on days 1 and 8, repeated every 4 weeks for 4 cycles, Thoracic radiotherapy 72 Gy/36 fractions |
| Registration date | Feb 3, 2009 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: